Europe – EU actions to support availability of medicines during COVID-19 pandemic – update #5

ThEU Executive Steering Group on Shortages of Medicines Caused by Major Events held a virtual meeting on 6 May 2020. Participation to the meeting of the Executive Steering Group was extended to all the heads of the national competent authorities (NCAs) of EU Member States to discuss additional actions by EU authorities to ensure the continued availability of medicines in Europe during the ongoing COVID-19 pandemic.

The steering group members and the heads of the NCAs discussed if the current way in which the supply of medicines used in intensive care units (ICUs) matches the demand at national level could be further improved in view of the reported shortages of ICU medicines. The heads of the NCAs agreed to explore how national data models to forecast the demand can be shared within the EU medicines regulatory network. The first step of this project would involve sharing best practices regarding the estimation of future needs by different Member States and exploring whether joint principles for data collection and analysis could be established. The steering group members and the heads of the NCAs agreed to further discuss this project and a reasonable timeline for its possible implementation at their next meeting…